Showing 91-100 of 1732 results for "".
Hemicrania Continua: A Question and Answer Review
https://practicalneurology.com/diseases-diagnoses/headache-pain/hemicrania-continua-a-question-and-answer-review/30785/A headache specialist explores the incidence, diagnosis, and treatment of this frequently misdiagnosed headache type.Physical Therapy for Low-Back Pain: How the Neurologist Can Facilitate Optimal Care
https://practicalneurology.com/diseases-diagnoses/headache-pain/PN0609_07-php/30911/Despite the frequency with which they order it, neurologists typically don't have formal training on the specifics of physical therapy. Here's how to make good referrals.In-Focus: Charting a New Course to Seizure Freedom
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/in-focus-charting-a-new-course-to-seizure-freedom/30315/Benefits of PFO Closure Confirmed in Publication of Trial Data
https://practicalneurology.com/diseases-diagnoses/stroke/benefits-of-pfo-closure-confirmed-in-publication-of-trial-data/30310/Relapse Management in Multiple Sclerosis: Corticosteroids Remain the Linchpin of Therapies
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/relapse-management-in-multiple-sclerosis-corticosteroids-remain-the-linchpin-of-therapies/32084/Several modalities are available for the treatment of multiple sclerosis relapse, including corticosteroids, intravenous immunoglobulins, and therapeutic apheresis.Updates in Bruton Tyrosine Kinase Inhibition for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/updates-in-bruton-tyrosine-kinase-inhibition-for-multiple-sclerosis/31975/Ongoing clinical trials will elucidate potential advantages and safety of these novel medications for future treatment of multiple sclerosis.Understanding Chiari Malformation Comorbidities
https://practicalneurology.com/diseases-diagnoses/headache-pain/understanding-chiari-malformation-comorbidities/31925/Part 2 of this special report reviews the comorbidities and trauma-related aggravation of Chiari type I malformations.MS Minute: Update on BTK Inhibitors for Multiple Sclerosis—A New Treatment That Brings New Hope
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/update-on-btk-inhibitors-for-multiple-sclerosis-a-new-treatment-that-brings-new-hope/40007/BTK inhibitors are the first class of medications to slow disability progression in secondary progressive multiple sclerosis without clinical relapses.Artificial Intelligence in Clinical Neurology: Opportunities, Limitations, and the Path Forward
https://practicalneurology.com/diseases-diagnoses/imaging-testing/artificial-intelligence-in-clinical-neurology-opportunities-limitations-and-the-path-forward/56386/Artificial intelligence is revolutionizing clinical neuroimaging by enhancing how neurologic conditions are diagnosed, prioritized, and managed, but its challenges must be addressed to ensure safe and fair use across diverse patient populations.Is Multiple Sclerosis a White Matter Disease or A Gray Matter Disease?
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/is-multiple-sclerosis-a-white-matter-disease-or-a-gray-matter-disease/30105/Damage to myelin, or white matter, is almost always present in multiple sclerosis and the disease has long been thought of as one in which the immune system attacks myelin. Yet damage to the cell that is wrapped in myelin also occurs. As with the chicken or the egg, the experts debate which comes fi